• Tags: cornea
Study: BioTissue's CAM improves recovery following corneal CXL
Research

Study: BioTissue's CAM improves recovery following corneal CXL

Research from AAO supports BioTissue’s Prokera as an FDA-cleared therapeutic device for use following epi-off CXL among keratoconus patients.
 Verséa Ophthalmics relaunches as DefEYE Inc
Business

Verséa Ophthalmics relaunches as DefEYE Inc

Ophthalmic biologics company makes official debut with the exclusive U.S. commercial rights to the BIOVANCE franchise of decellularized biologics.
Kala's phase 2b PCED trial fails to meet primary goal
Pipeline

Kala's phase 2b PCED trial fails to meet primary goal

Company plans to cease development of lead asset KPI-012 as the CHASE study also falls short of achieving statistical significance for secondary endpoints.
Are corneal dystrophies linked to mental health conditions?
Research

Are corneal dystrophies linked to mental health conditions?

Study highlights the importance of assessing corneal dystrophy patients’ psychological well-being.
FDA reportedly clears Moria Surgical's corneal storage solution
Products

FDA reportedly clears Moria Surgical's corneal storage solution

XTRA4 is designed to preserve refrigerated human donor corneas for up to 14 days—reducing risk for graft detachments and improving availability for corneal transplant patients.
Unique anterior stromal puncture device targets RCEs
Products

Unique anterior stromal puncture device targets RCEs

VEO Ophthalmics and Plexitome Medical’s partnership includes commerical launch of a new ASP method that allows treatment in the optical axis—without scarring.
Ziemer USA unveils new CTAK module for GALILEI diagnostic platform
Products

Ziemer USA unveils new CTAK module for GALILEI diagnostic platform

Latest addition to the FDA-cleared diagnostic device combines high-resolution corneal tomography with laser-guided stromal inlay preparation for customized corneal reshaping.
Haag-Streit launches corneal map for the Lenstar 900
Products

Haag-Streit launches corneal map for the Lenstar 900

The optical biometer’s newest integratable feature enables simultaneous measurement of a wider range of biometric parameters for cataract surgery planning.
Allotex submits IDE to FDA for collagen-based corneal implant
Pipeline

Allotex submits IDE to FDA for collagen-based corneal implant

Company is seeking to conduct a U.S. clinical trial on its tissue addition technology procedure that augments the cornea using precision-shaped human collagen.
ADHD medication may lead to corneal cell changes in pediatric patients
Research

ADHD medication may lead to corneal cell changes in pediatric patients

Study notes differences in key parameters of corneal and retinal health in patients taking methylphenidate.
Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology
Business

Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology

Co-founder Michael Mrochen, PhD, will assume leadership as the startup seeks an IDE for its biocompatible procedure for vision correction.
B+L launches Zenlens CHROMA HOA scleral contact lenses
Products

B+L launches Zenlens CHROMA HOA scleral contact lenses

Newest addition to the scleral lens brand features a custom-designed, wavefront-guided scleral lens technology intended to correct advanced HOA.
FDA grants Fast Track designation to OKYO Pharma's NCP therapeutic
Pipeline

FDA grants Fast Track designation to OKYO Pharma's NCP therapeutic

New status gives urcosimod an expedited pathway toward potential market approval as first approved treatment for this patient base.
Could a CXL and customized PRK combo provide better keratoconus outcomes?
Research

Could a CXL and customized PRK combo provide better keratoconus outcomes?

Literature review finds combined procedure provides superior visual acuity and quality.
Voiant acquires AI-based ophthalmic image analysis startup Voxeleron
Business

Voiant acquires AI-based ophthalmic image analysis startup Voxeleron

Software and clinical trial expertise to combine into an AI-based integrated platform for retinal and corneal imaging, with a goal of expedited patient treatment delivery.
OKYO's urcosimod demonstrates long-term stability for NCP
Pipeline

OKYO's urcosimod demonstrates long-term stability for NCP

With a real-world study ongoing, urcosimod’s +2.5-year shelf stability further supports a potential NDA submission for regulatory approval down the road.
Pantheon Vision and Eyedeal Medical to develop bioengineered corneal implant
Business

Pantheon Vision and Eyedeal Medical to develop bioengineered corneal implant

Collaboration involves advancement and commercialization of Pantheon’s artificial cornea as the company nears a potential premarket approval submission.
Alcon purchases majority stake in Aurion Biotech
Business

Alcon purchases majority stake in Aurion Biotech

Company replaces CEO and founder Greg Kunst, gaining access to groundbreaking CED cell therapy with plans for phase 3 clinical trials expected later this year.
Rare tooth-in-eye surgery restores vision in the blind
Research

Rare tooth-in-eye surgery restores vision in the blind

First patients in Canada undergo osteo-odonto keratoprosthesis to regain eyesight after severe corneal blindness.
OKYO Pharma seeks Fast Track designation for NCP candidate
Pipeline

OKYO Pharma seeks Fast Track designation for NCP candidate

Designation would give urcosimod (formerly OK-101) an expedited pathway to potentially become the first approved treatment for this orphan disease.